Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

¥22.54As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300357Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 7.02%
Div yield 1.11%
ROE 14.50%
Drug Manufacturers (General)
Beta (5Y) 0.39
PE TTM 27.62
TSR TTM (32.98%)
Mkt cap ¥11.80B
ROIC 25.92%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥24
4.47%
(34.93%)
Buy 4|0|7|10|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.29
0.29
0.31
0.30
19.37%
16.20%
22.92%
13.18%
Revenue¥B
1.259
1.269
1.326
1.396
3.57%
(0.73%)
6.60%
13.04%
Peers (US$1.769B)
Cap (US$)
PE
1.545B
—
1.879B
20.53x
Capital
TTM
5Y
10Y
Leveragex
4.788
(0.149)
(0.142)
EBIT/Intx
0.863
0.735
0.696
Own earn%
(14.52)
(39.68)
(19.94)
Sh yield%
46.29
31.73
36.42
Owners
Insiders/Inst%
0.43
60.19
Short interest%
1.16
SBC / revenue%
5.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
11–18
$1 testx
0.0
Incr. ROIC%
16